Cargando…
Effectiveness and Safety of Botulinum Toxin Type A in the Treatment of Androgenetic Alopecia
BACKGROUND: Androgenetic alopecia (AGA) represents the most frequent clinical complaint encountered by dermatologists and is characterized by a progressive miniaturization of the hair follicle. However, the efficacy and safety of current medical treatment remain limited, and more personalized therap...
Autores principales: | Zhou, Yaguang, Yu, Shui, Zhao, Jimin, Feng, Xinyue, Zhang, Meinan, Zhao, Zigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424364/ https://www.ncbi.nlm.nih.gov/pubmed/32802833 http://dx.doi.org/10.1155/2020/1501893 |
Ejemplares similares
-
A Pilot Study to Evaluate Effectiveness of Botulinum Toxin in Treatment of Androgenetic Alopecia in Males
por: Singh, Sehdev, et al.
Publicado: (2017) -
Androgenetic alopecia: An update
por: Ntshingila, Sincengile, et al.
Publicado: (2023) -
Topical Melatonin for Treatment of Androgenetic Alopecia
por: Fischer, Tobias W, et al.
Publicado: (2012) -
Mesotherapy with Dutasteride in the Treatment of Androgenetic Alopecia
por: Saceda-Corralo, David, et al.
Publicado: (2017) -
Regenerative Medicine Treatments for Androgenetic Alopecia
por: Mysore, Venkataram, et al.
Publicado: (2021)